HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Percutaneous transhepatic cholangiography and intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction.

AbstractPURPOSE:
To determine the safety and feasibility of percutaneous transhepatic cholangiography (PTC) and intraductal radiofrequency (RF) ablation combined with biliary stent placement for malignant biliary obstruction.
MATERIALS AND METHODS:
Data from patients with unresectable malignant biliary obstruction who underwent PTC, intraductal RF ablation, and biliary stent placement (n = 12) or PTC and biliary stent placement only (control group; n = 14) were reviewed. Postoperative complications, jaundice remission, and stent patency were assessed.
RESULTS:
All procedures were successful. No severe complications (eg, biliary bleeding, perforation) occurred. Two experimental group patients developed cholangitis, which resolved with conservative treatment. The 1-week jaundice remission and 3-month stent patency rates were similar in both groups, but the 6-month stent patency rate was higher in the experimental group (P < .05). In the experimental group, one death occurred as a result of gastrointestinal hemorrhage (unrelated to stent placement) by 3 months, and there were two cases of recurrent jaundice by 6 months. The latter two patients underwent repeat PTC, ablation, and stent placement. In the control group, one death occurred as a result of hepatic failure caused by progressive jaundice at 3 months, and another death resulted from disseminated intravascular coagulation caused by jaundice recurrence at 138 days after stent placement. In addition, seven patients developed jaundice recurrence (50-151 d after stent placement). PTC and repeat stent placement were performed in these patients.
CONCLUSIONS:
Percutaneous transhepatic cholangiography and intraductal RF ablation combined with biliary stent placement for malignant biliary obstruction is safe and feasible and effectively prolongs stent patency time.
AuthorsTeng-Fei Li, Guo-Hao Huang, Zhen Li, Chang-Fu Hao, Jian-Zhuang Ren, Xu-Hua Duan, Kai Zhang, Chen Chen, Xin-Wei Han, De-Chao Jiao, Meng-Fan Zhang, Yan-Li Wang
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) Vol. 26 Issue 5 Pg. 715-21 (May 2015) ISSN: 1535-7732 [Electronic] United States
PMID25817458 (Publication Type: Journal Article)
CopyrightCopyright © 2015 SIR. Published by Elsevier Inc. All rights reserved.
Topics
  • Bile Duct Neoplasms (complications)
  • Catheter Ablation
  • Cholangiography (methods)
  • Cholestasis (diagnostic imaging, surgery)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications
  • Stents
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: